VBI Vaccines Inc (NASDAQ: VBIV) shares were in penny stock territory Monday following the release of data from a late-stage study of its hepatitis B virus vaccine candidate. The thinly traded …
More VBI Shares Plunge On Mixed Late-Stage Hepatitis B Vaccine Trial Results Videos